NasdaqGS:MASI

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

US$13.2b

Last Updated

2021/06/24 03:41 UTC

Data Sources

Company Financials +

Executive Summary

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. More Details


Snowflake Analysis

Flawless balance sheet with acceptable track record.


Similar Companies

Share Price & News

How has Masimo's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MASI is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: MASI's weekly volatility (4%) has been stable over the past year.


Market Performance


7 Day Return

6.8%

MASI

3.0%

US Medical Equipment

0.5%

US Market


1 Year Return

7.9%

MASI

41.4%

US Medical Equipment

42.6%

US Market

Return vs Industry: MASI underperformed the US Medical Equipment industry which returned 41.4% over the past year.

Return vs Market: MASI underperformed the US Market which returned 42.6% over the past year.


Shareholder returns

MASIIndustryMarket
7 Day6.8%3.0%0.5%
30 Day9.8%3.5%1.9%
90 Day6.1%10.8%7.9%
1 Year7.9%7.9%42.6%41.4%44.9%42.6%
3 Year145.7%145.7%72.3%68.1%64.4%54.1%
5 Year364.9%364.9%155.1%136.6%128.3%102.7%

Long-Term Price Volatility Vs. Market

How volatile is Masimo's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Masimo undervalued compared to its fair value and its price relative to the market?

57.55x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: MASI ($239.7) is trading above our estimate of fair value ($191.99)

Significantly Below Fair Value: MASI is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: MASI is good value based on its PE Ratio (57.5x) compared to the US Medical Equipment industry average (58.8x).

PE vs Market: MASI is poor value based on its PE Ratio (57.5x) compared to the US market (19.2x).


Price to Earnings Growth Ratio

PEG Ratio: MASI is poor value based on its PEG Ratio (4.4x)


Price to Book Ratio

PB vs Industry: MASI is overvalued based on its PB Ratio (9.9x) compared to the US Medical Equipment industry average (4.7x).


Future Growth

How is Masimo forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

13.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MASI's forecast earnings growth (13% per year) is above the savings rate (2%).

Earnings vs Market: MASI's earnings (13% per year) are forecast to grow slower than the US market (15.7% per year).

High Growth Earnings: MASI's earnings are forecast to grow, but not significantly.

Revenue vs Market: MASI's revenue (7.1% per year) is forecast to grow slower than the US market (9.5% per year).

High Growth Revenue: MASI's revenue (7.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MASI's Return on Equity is forecast to be low in 3 years time (20%).


Past Performance

How has Masimo performed over the past 5 years?

3.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MASI has high quality earnings.

Growing Profit Margin: MASI's current net profit margins (19.5%) are lower than last year (21.6%).


Past Earnings Growth Analysis

Earnings Trend: MASI's earnings have grown by 3.5% per year over the past 5 years.

Accelerating Growth: MASI's earnings growth over the past year (8.1%) exceeds its 5-year average (3.5% per year).

Earnings vs Industry: MASI earnings growth over the past year (8.1%) underperformed the Medical Equipment industry 11.1%.


Return on Equity

High ROE: MASI's Return on Equity (17.3%) is considered low.


Financial Health

How is Masimo's financial position?


Financial Position Analysis

Short Term Liabilities: MASI's short term assets ($983.1M) exceed its short term liabilities ($196.9M).

Long Term Liabilities: MASI's short term assets ($983.1M) exceed its long term liabilities ($72.8M).


Debt to Equity History and Analysis

Debt Level: MASI is debt free.

Reducing Debt: MASI has no debt compared to 5 years ago when its debt to equity ratio was 83.4%.

Debt Coverage: MASI has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: MASI has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Masimo current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MASI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MASI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MASI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MASI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MASI's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.2yrs

Average management tenure


CEO

Joe Kiani (55 yo)

32.42yrs

Tenure

US$15,493,723

Compensation

Mr. Joseph E. Kiani, also known as Joe, founded Masimo Corporation in 1989 and has been its Chairman and Chief Executive Officer since 1989. Mr. Kiani serves as the Chairman and Chief Executive Officer of ...


CEO Compensation Analysis

Compensation vs Market: Joe's total compensation ($USD15.49M) is above average for companies of similar size in the US market ($USD11.28M).

Compensation vs Earnings: Joe's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: MASI's management team is seasoned and experienced (8.2 years average tenure).


Board Members

Experienced Board: MASI's board of directors are considered experienced (5.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Masimo Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Masimo Corporation
  • Ticker: MASI
  • Exchange: NasdaqGS
  • Founded: 1989
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$13.184b
  • Shares outstanding: 55.00m
  • Website: https://www.masimo.com

Number of Employees


Location

  • Masimo Corporation
  • 52 Discovery
  • Irvine
  • California
  • 92618
  • United States

Listings


Biography

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse ox...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/24 03:41
End of Day Share Price2021/06/23 00:00
Earnings2021/04/03
Annual Earnings2021/01/02


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.